Security key
28617K101
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 8,917,722
- Share change
- -135,648
- Total reported value
- $12,217,005
- Price per share
- $1.37
- Number of holders
- 28
- Value change
- -$186,914
- Number of buys
- 11
- Number of sells
- 16
Report period
Q3 2023
Institutions
28
Top holders
10
ELDN full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Eledon Pharmaceuticals, Inc. SEC filings
Eledon Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28617K101
Recent filing periods:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
5.5%
|
4,326,710
|
$5,927,593 | — | 30 Jun 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.3%
|
1,842,803
|
$2,524,640 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.86%
|
679,557
|
$930,993 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.66%
|
516,675
|
$707,845 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.56%
|
443,001
|
$606,911 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.35%
|
273,055
|
$374,000 | — | 30 Jun 2023 | |
| CM Management, LLC |
13F
|
Company |
0.3%
|
234,803
|
$322,000 | — | 30 Jun 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.28%
|
221,830
|
$303,908 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
169,650
|
$232,420 | — | 30 Jun 2023 | |
| JMAC ENTERPRISES LLC |
13F
|
Company |
0.1%
|
80,041
|
$109,656 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
60,373
|
$83,000 | — | 30 Jun 2023 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.06%
|
50,849
|
$70,000 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
50,502
|
$69,188 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
44,692
|
$61,228 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
43,002
|
$58,913 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
30,053
|
$41,173 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
28,302
|
$38,774 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
23,000
|
$31,510 | — | 30 Jun 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
22,050
|
$30,209 | — | 30 Jun 2023 | |
| SVB FINANCIAL GROUP |
13F
|
Company |
0.02%
|
18,025
|
$24,694 | — | 30 Jun 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
17,675
|
$24,000 | — | 30 Jun 2023 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.02%
|
16,726
|
$23,000 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
15,783
|
$21,623 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
14,987
|
$20,532 | — | 30 Jun 2023 | |
| Veritable, L.P. |
13F
|
Company |
0.02%
|
13,029
|
$17,850 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
11,450
|
$15,687 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
10,586
|
$14,503 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
7,740
|
$10,604 | — | 30 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
5,918
|
$8,108 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,155
|
$2,952 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
146
|
$200 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
32
|
$44 | — | 30 Jun 2023 | |
| Gary A. Lyons |
3/4/5
|
Director |
—
class O/S missing
|
150,437
|
$673,958 | — | 01 May 2023 | |
| Walter C. Ogier |
3/4/5
|
Director |
—
class O/S missing
|
150,437
|
— | — | 01 May 2023 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q3 2023
As of 30 Sep 2023,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,917,722 shares.
The largest 10 holders included
BVF INC/IL, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Woodline Partners LP, Ensign Peak Advisors, Inc, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Royal Bank of Canada, RENAISSANCE TECHNOLOGIES LLC, and JMAC ENTERPRISES LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
32
Q3 2023 holders
28
Holder diff
-4
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.